v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:      
Net income $ 1,106 $ 518 $ 740
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, amortization, and impairment 1,479 722 595
Net periodic benefit cost 31 32 12
Amortization of debt discount and deferred financing costs 48 36 10
Net gain on disposal of property, plant, and equipment (49) (7) (11)
Net gain on disposal of businesses and investments (54) (8) 0
Equity in (income)/loss of affiliated companies (5) (3) 4
Net foreign exchange loss 5 9 27
Share-based compensation 83 74 32
Inventory step-up amortization (6) 133 0
Other, net (146) 60 (37)
Loss from highly inflationary accounting for Argentine subsidiaries 28 27 106
Deferred income taxes, net (96) (125) (37)
Changes in operating assets and liabilities, excluding effect of acquisitions, divestitures, and currency:      
Trade receivables (323) (228) (43)
Inventories (329) 0 95
Prepaid expenses and other current assets (51) (57) (5)
Trade payables 570 220 (43)
Other current liabilities 16 15 (74)
Accrued employee costs 3 47 8
Employee benefit obligations (78) (47) (39)
Other, net (81) (28) (19)
Net cash provided by operating activities 2,151 1,390 1,321
Cash flows from investing activities:      
Investments in affiliated companies and other 0 0 (3)
Business acquisitions (17) (1,653) (20)
Purchase of property, plant, and equipment, and other intangible assets (922) (580) (492)
Proceeds from divestitures, net of cash divested 272 113 0
Proceeds from sale of affiliated companies and other investments 70 0 0
Proceeds from sales of property, plant, and equipment, and other intangible assets 73 18 39
Net cash used in investing activities (524) (2,102) (476)
Cash flows from financing activities:      
Proceeds from exercise of options 6 15 0
Purchase of treasury shares and tax withholdings for share-based incentive plans (71) (122) (51)
Purchase of non-controlling interest (1) (2) 0
Proceeds from issuance of long-term debt 3,214 2,181 1,024
Repayment of long-term debt (2,893) (506) (16)
Financing-related transaction fees 0 (11) 0
Net borrowing/(repayment) of commercial paper (389) 228 (1,041)
Net borrowing/(repayment) of short-term debt 3 (16) (10)
Repayment of lease liabilities (16) (12) (11)
Share buyback/cancellations (1) 0 (30)
Dividends paid (1,195) (845) (722)
Net cash (used in)/provided by financing activities (1,343) 910 (857)
Effect of exchange rates on cash and cash equivalents 4 41 (89)
Net increase/(decrease) in cash and cash equivalents 288 239 (101)
Cash and cash equivalents balance at beginning of the fiscal year   827 588
Cash and cash equivalents balance at end of the fiscal year $ 1,115 $ 827 $ 588